Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study).
Pagani S, Lombardi N, Crescioli G, Vighi GV, Spada G, Romoli I, Andreetta P, Capuano A, Marrazzo E, Marra A, Leoni O, Vannacci A, Venegoni M, Vighi GD; MEREAFaPS Study group. Pagani S, et al. Among authors: marra a. Intern Emerg Med. 2021 Apr;16(3):741-748. doi: 10.1007/s11739-020-02521-x. Epub 2021 Jan 4. Intern Emerg Med. 2021. PMID: 33392971
Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study).
Lombardi N, Crescioli G, Bettiol A, Tuccori M, Capuano A, Bonaiuti R, Mugelli A, Venegoni M, Vighi GD, Vannacci A; MEREAFaPS Study group. Lombardi N, et al. Front Pharmacol. 2020 Apr 6;11:412. doi: 10.3389/fphar.2020.00412. eCollection 2020. Front Pharmacol. 2020. PMID: 32327995 Free PMC article.
Pancytopenia associated with levetiracetam treatment.
Gallerani M, Mari E, Boari B, Carletti R, Marra A, Cavallo M. Gallerani M, et al. Among authors: marra a. Clin Drug Investig. 2009;29(11):747-51. doi: 10.2165/11319450-000000000-00000. Clin Drug Investig. 2009. PMID: 19813778
APOBEC3 mutagenesis drives therapy resistance in breast cancer.
Gupta A, Gazzo A, Selenica P, Safonov A, Pareja F, da Silva EM, Brown DN, Zhu Y, Patel J, Blanco-Heredia J, Stefanovska B, Carpenter MA, Pei X, Frosina D, Jungbluth AA, Ladanyi M, Curigliano G, Weigelt B, Riaz N, Powell SN, Razavi P, Harris RS, Reis-Filho JS, Marra A, Chandarlapaty S. Gupta A, et al. Among authors: marra a. bioRxiv [Preprint]. 2024 May 1:2024.04.29.591453. doi: 10.1101/2024.04.29.591453. bioRxiv. 2024. PMID: 38746158 Free PMC article. Preprint.
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.
Boscolo Bielo L, Repetto M, Crimini E, Belli C, Setola E, Parma G, Fusco N, Barberis M, Guerini Rocco E, Marra A, Colombo N, Curigliano G. Boscolo Bielo L, et al. Among authors: marra a. Oncologist. 2024 May 8:oyae082. doi: 10.1093/oncolo/oyae082. Online ahead of print. Oncologist. 2024. PMID: 38716772 Free article.
992 results